Bernhard Fischer
Company: Apeptico
Job title: Chief Executive Officer
Seminars:
Panel Discussion: Determining the Extent the Understandings Gained from Covid-19 ARDS Can Be Translated Into ARDS 2:55 pm
day: Day Two
Clinical Development of Solnatide Peptide for the Therapeutic Treatment of ARDS During the Coronavirus Pandemic 12:45 pm
Reviewing solnatide peptide and its capacity to activate pulmonary edema clearance and highlighting the molecular structure and interaction with the pulmonary ENaC channel Exploring basic characteristics of ARDS patients Vs. COVID-19 patients to illuminate whether ARDS pneumonia behaves similarly to viral/COVID pneumonia Navigating the limitation in hospital management during pandemics Delving into clinical trials to…Read more
day: Day Two